Analytical Data
-
Gene name
DDTL
- Application
-
Alternative Names
(D-dopachrome tautomerase-like protein)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6NHG4
-
Expression Region
1-134aa
-
Molecular Weight
21.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DDTL (Double-Domain Toxin-Like) recombinant proteins have garnered significant attention in the field of biochemistry and molecular biology due to their unique structural and functional properties. Originally inspired by natural toxin proteins, which exhibit potent biological activities, researchers have sought to harness the potential of DDTL proteins for various applications, including therapeutic development and biotechnological innovations. The study of DDTL proteins is driven by their dual-domain architecture, which allows for enhanced specificity and functionality by combining distinct biochemical properties from each domain. This has opened avenues for creating novel biosensors, targeted drug delivery systems, and therapeutic agents with reduced side effects. Additionally, DDTLs' capacity for engineering and modification makes them valuable candidates in the ongoing quest to design more effective and safe biomolecules. Research has focused on elucidating the mechanisms of action of these proteins, optimizing their production in recombinant systems, and exploring their interactions with biological targets. As a result, DDTL proteins represent a promising frontier in the development of advanced materials and therapeutics, with the potential to address various challenges in medicine and biotechnology.
